By: McKesson RxO
Read time: 1 minute
Read our latest Q & A to help health systems navigate the world of biosimilars
Biosimilars are important to health system customers because of their ability to help manage chronic conditions at lower costs to patient and providers, but there are many key areas that health systems should consider when adopting biosimilars.
Download this informative Q & A to learn more about potential challenges, cost benefits, and how health systems can prepare for the future when it comes to biosimilars.
Learn how the McKesson RxO Utilization Analytics tool can help health system customers with their biosimilar utilization.